Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock

September 15, 2021
2:23 am

Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock

WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Avalo or the Company) (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

These Coins Are the Most Talked About in Crypto!

June 30, 2026

US finance app SoFi acquires Composer to add AI investing strategies

June 30, 2026

Can RKLB Extend Its Rally After a Record Contract Win?

June 30, 2026

UK finalizes stablecoin and crypto framework with no explicit systemic threshold – Ledger Insights

June 30, 2026

Texas Instruments Inc Stock (TXN) Moved Up by 3.40% on Jun 30: A Full Analysis

June 30, 2026

QuantRate Launches Free AI Trading Solution for Crypto, Stocks, ETFs, and Forex Investors

June 30, 2026

MSTR Stock Price Prediction: Here’s Why Strategy May Crash to $50

June 30, 2026

$1.5 Billion a Month, but Not Yet Infrastructure

June 30, 2026